Intravenous immune globulin in chronic lymphocytic leukaemia.
The most common complication of chronic lymphocytic leukaemia (CLL) is infection, which occurs mainly in advanced stages of disease or in those patients with hypogammaglobulinaemia. Intravenous immune globulin (IVIG) has been shown to be a useful prophylactic therapy against infections in such patie...
| Main Authors: | , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
1994
|